The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Open accessAbstract
OBJECTIVES: To determine the risk of stroke associated with oral and transdermal routes of administration of hormone replacement therapy. DESIGN: Population based nested case-control study. Setting About 400 general practices in the United Kingdom contributing to the General Practice Research Database. Participants Cohort of all women in the database aged 50-79 years between 1 January 1987 and 31 October 2006 who were members of a practice that fulfilled predefined quality criteria and without a diagnosis of stroke before cohort entry. For each case of stroke occurring during follow-up, up to four controls were selected from among the cohort members in the risk sets defined by the case. Exposure to hormone replacement therapy (HRT) was categorised into oestrogens only, oestrogens plus progestogen, progestogen only, and tibolone. Oestrogens were further subdivided according to the route of administration (oral v transdermal) and dose (high v low). Main outcome measures Rate ratio of stroke associated with current use of oral and transdermal HRT compared with no use. Current use was considered as a prescription whose duration included the index date. RESULTS: There were 15,710 cases of stroke matched to 59 958 controls. The rate of stroke in the cohort was 2.85 per 1000 per year. The adjusted rate ratio of stroke associated with current use of transdermal HRT was 0.95 (95% CI 0.75 to 1.20) relative to no use. The risk of stroke was not increased with use of low oestrogen dose patches (rate ratio 0.81(0.62 to 1.05)) compared with no use, whereas the risk was increased with high dose patches (rate ratio 1.89 (1.15 to 3.11)). Current users of oral HRT had a higher rate of stroke than non-users (rate ratio 1.28 (1.15 to 1.42)) with both low dose and high dose. CONCLUSIONS: The use of transdermal HRT containing low doses of oestrogen does not seem to increase the risk of stroke. The presence of residual confounding, however, cannot be entirely excluded in the interpretation of this finding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · JAMA · doi:10.1001/jama.297.13.1465 · Cited by 1,741
Wassertheil-Smoller, S., Hendrix, S., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., Kotchen, T., Curb, J. D., Black, H., Rossouw, J. E., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2673 · Cited by 1,159
A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Self-citationCanonico, M., Oger, E., Plu-Bureau, G., Conard, J., Meyer, G., Lévesque, H., Trillot, N., Barrellier, M.-T., Wahl, D., Emmerich, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.642280 · Cited by 864
Jick, H., Jick, S. S., & Derby, L. E. (1991) · BMJ · doi:10.1136/bmj.302.6779.766 · Cited by 839
Risk of venous thromboembolism in users of hormone replacement therapy
Daly, E., Vessey, M. P., Hawkins, M. M., Carson, J. L., Gough, P., & Marsh, S. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07113-9 · Cited by 819
Scarabin, P.-Y., Oger, E., & Plu-Bureau, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14066-4 · Cited by 714
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 623
Validity of the General Practice Research Database
Jick, S. S., Kaye, J. A., Vasilakis‐Scaramozza, C., Rodríguez, L. A. G., Ruigómez, A., Meier, C. R., Schlienger, R. G., Black, C., & Jick, H. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.5.686.32205 · Cited by 584
Canonico, M., Plu-Bureau, G., Lowe, G. D. O., & Scarabin, P.-Y. (2008) · BMJ · doi:10.1136/bmj.39555.441944.be · Cited by 569
Use of the UK General Practice Research Database for pharmacoepidemiology
García Rodríguez, L. A., & Pérez Gutthann, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00701.x · Cited by 558
Simon, J. A., Hsia, J., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E., & Hulley, S. B. (2001) · Circulation · doi:10.1161/01.cir.103.5.638 · Cited by 403
Effects of Conjugated Equine Estrogen on Stroke in the Women’s Health Initiative
Hendrix, S. L., Wassertheil-Smoller, S., Johnson, K. C., Howard, B. V., Kooperberg, C., Rossouw, J. E., Trevisan, M., Aragaki, A., Baird, A. E., Bray, P. F., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.594077 · Cited by 359
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study
Gutthann, S. P., Rodriguez, L. A. G., Castellsague, J., & Oliart, A. D. (1997) · BMJ · doi:10.1136/bmj.314.7083.796 · Cited by 338
(2002) · The Lancet · doi:10.1016/s0140-6736(02)12001-0 · Cited by 333
Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice
Hall, G. C., Brown, M. M., Mo, J., & MacRae, K. D. (2004) · Neurology · doi:10.1212/01.wnl.0000110312.36809.7f · Cited by 296
Clarke, S. (2002) · BJOG: An International Journal of Obstetrics and Gynaecology · doi:10.1016/s1470-0328(02)01544-6 · Cited by 267
Association between hormone replacement therapy and subsequent stroke: a meta-analysis
Bath, P. M. W., & Gray, L. J. (2005) · BMJ · doi:10.1136/bmj.38331.655347.8f · Cited by 236
(2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.06.061 · Cited by 214
Straczek, C., Oger, E., Yon de Jonage-Canonico, M. B., Plu-Bureau, G., Conard, J., Meyer, G., Alhenc-Gelas, M., Lévesque, H., Trillot, N., Barrellier, M.-T., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.565556 · Cited by 200
Sare, G. M., Gray, L. J., & Bath, P. M. W. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn299 · Cited by 188
Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause
Rossouw, J. E., Prentice, R. L., Manson, J. E., Wu, L., Barad, D., Barnabei, V. M., Ko, M., LaCroix, A. Z., Margolis, K. L., & Stefanick, M. L. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000275404.76075.72 · Cited by 160
Hormone Replacement Therapy and Incidence of Acute Myocardial Infarction
Varas‐Lorenzo, C., García‐Rodríguez, L. A., Perez‐Gutthann, S., & Oliart, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.22.2572 · Cited by 150
A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200203000-00019 · Cited by 125
Self-citationCanonico, M., Oger, E., Conard, J., Meyer, G., Levesque, H., Trillot, N., Barrellier, M. ‐., Wahl, D. G., Emmerich, J., & Scarabin, P. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01933.x · Cited by 113
Cyclooxygenase-2 Selective Nonsteroidal Anti-Inflammatory Drugs and the Risk of Ischemic Stroke
Andersohn, F., Schade, R., Suissa, S., & Garbe, E. (2006) · Stroke · doi:10.1161/01.str.0000226642.55207.94 · Cited by 98
Self-citationPlace, V. A., Powers, M. S., Darley, P. E., Schenkel, L., & Good, W. R. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90568-x · Cited by 86
New evidence regarding hormone replacement therapies is urgently required
Modena, M. G., Sismondi, P., Mueck, A. O., Kuttenn, F., Lignieres, B. D., Verhaeghe, J., Foidart, J. M., Caufriez, A., & Genazzani, A. R. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.05.003 · Cited by 76
Systematic review: Hormone therapy and cardiovascular disease: a systematic review and meta‐analysis
Magliano, D. J., Rogers, S., Abramson, M. J., & Tonkin, A. M. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2005.00797.x · Cited by 71
Hemelaar, M., van der Mooren, M. J., Rad, M., Kluft, C., & Kenemans, P. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.07.1298 · Cited by 69
Meikle, A. W. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79192-3 · Cited by 55
Wassertheil-Smoller, S. W., Hendrix, S. L., Limacher, M. C., et al. (2003) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000093671.39203.32 · Cited by 52
Hormone therapy and cerebrovascular events: a population-based nested case-control study
Arana, A., Varas‐Lorenzo, C., González‐Pérez, A., Gutiérrez, L., Bjerrum, L., & Rodríguez, L. A. G. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000233494.28335.71 · Cited by 43
Percutaneous 17β-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women
Archer, D. F. (2003) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000070526.74726.8a · Cited by 37
Simon, J. A., Hsia, J., & Cauley, J. A. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00300-2 · Cited by 25
Myocardial infarction risk and hormone replacement: Differences between products
de Vries, C. S., Bromley, S. E., & Farmer, R. D. T. (2005) · Maturitas · doi:10.1016/j.maturitas.2005.06.004 · Cited by 19
Hormone replacement therapy use and the risk of stroke
Renoux, C., Dell’Aniello, S., Garbe, E., & Suissa, S. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.09.020 · Cited by 17
Self-citationHormone replacement therapy and risk of venous thromboembolism: population based case control study
Perez‐Gutthann, S., Rodríguez, L. A. G., Castellsagué, J., & Oliart, A. D. (1997) · Maturitas · doi:10.1016/s0378-5122(97)06004-0 · Cited by 16
Simon, J. A., Hsia, J. A., Cauley, J. A., Richards, C., Harris, F., Fong, J., Barrett-Connor, E. L., & Hulley, S. B. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200107000-00021 · Cited by 15
Cited by
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596
Metadata
- Authors
- Renoux, C., Dell'Aniello, S., Garbe, E., & Suissa, S.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2010-06-03
- Volume
- 340
- Issue
- jun03 4
- Pages
- c2519-c2519
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2169398990
- Cited by
- 386
- References
- 40
- FWCI
- 22.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.